Covered recipient · General Payments record
LESLEY K WHITE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,211.50
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $892.06 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Behring | $257.13 | 11 |
| Genentech USA, Inc. | $162.52 | 3 |
| Lilly USA, LLC | $116.19 | 2 |
| Amgen Inc. | $84.21 | 5 |
| GlaxoSmithKline, LLC. | $61.65 | 4 |
| Acerta Pharma LLC | $58.39 | 4 |
| ABBVIE INC. | $58.21 | 3 |
| Kaleo, Inc. | $36.58 | 2 |
| Octapharma USA, Inc. | $28.69 | 1 |
| Hikma Pharmaceuticals USA | $14.72 | 1 |
| OptiNose US, Inc. | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.26 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108404132 | CMS |
| ABBVIE INC. | $13.72 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108404134 | CMS |
| ABBVIE INC. | $25.23 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108404136 | CMS |
| Amgen Inc. | $16.08 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117413998 | CMS |
| Amgen Inc. | $18.60 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414000 | CMS |
| Amgen Inc. | $14.64 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414002 | CMS |
| Amgen Inc. | $18.43 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414004 | CMS |
| Amgen Inc. | $16.46 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117414006 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.43 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105857090 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.14 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105876971 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.30 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104665565 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.52 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105784506 | CMS |
| CSL Behring | $33.71 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660223 | CMS |
| CSL Behring | $21.80 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660229 | CMS |
| CSL Behring | $17.55 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660243 | CMS |
| CSL Behring | $17.22 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660245 | CMS |
| CSL Behring | $17.60 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660249 | CMS |
| CSL Behring | $20.38 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660251 | CMS |
| CSL Behring | $28.07 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660255 | CMS |
| CSL Behring | $27.66 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660271 | CMS |
| CSL Behring | $21.39 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660275 | CMS |
| CSL Behring | $21.93 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660283 | CMS |
| CSL Behring | $29.82 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134660285 | CMS |
| Genentech USA, Inc. | $18.67 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133170499 | CMS |
| Genentech USA, Inc. | $24.15 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133170497 | CMS |
| Genentech USA, Inc. | $119.70 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133170501 | CMS |
| GlaxoSmithKline, LLC. | $13.58 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115740686 | CMS |
| GlaxoSmithKline, LLC. | $15.26 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116093901 | CMS |
| GlaxoSmithKline, LLC. | $14.99 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116530260 | CMS |
| GlaxoSmithKline, LLC. | $17.82 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116660761 | CMS |
| Hikma Pharmaceuticals USA | $14.72 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127504380 | CMS |
| kaleo, Inc. | $16.98 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126633555 | CMS |
| kaleo, Inc. | $19.60 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126633557 | CMS |
| Lilly USA, LLC | $16.30 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135787812 | CMS |
| Lilly USA, LLC | $99.89 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135796306 | CMS |
| Octapharma USA, Inc. | $28.69 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142324028 | CMS |
| Optinose US, Inc. | $13.77 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142177428 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.